Methodology for clinical trials in cancer patients with febrile neutropenia. Do we have a consensus?
R
R
Feld
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D002986:Clinical Trials as Topic / Q000592:standards*; D005334:Fever / Q000150:complications / Q000188:drug therapy; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced* / Q000188:drug therapy; D012107:Research Design / Q000592:standards*
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents